| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/19/2023 | PhaseBio Pharmaceuticals Inc | PHAS | Exercise | Restricted Stock Units | 3.8k | $0.00 | $0 | | 05/19/2023 |
| 01/25/2023 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 25k | $7.80 | $195k | | 01/25/2023 |
| 05/19/2022 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Restricted Stock Units | 3.8k | $0.00 | $0 | | 05/19/2022 |
| 05/19/2022 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Non-employee Director Stock Option (right to buy) | 17.5k | $0.84 | $14.7k | | 05/19/2022 |
| 03/07/2022 | ZOGENIX, INC. | ZGNX | Disposition | Stock Option (Right to Buy) | 22k | $17.83 | $392.3k | | 03/07/2022 |
| 03/07/2022 | ZOGENIX, INC. | ZGNX | Disposition | Stock Option (Right to Buy) | 20k | $22.82 | $456.4k | | 03/07/2022 |
| 01/25/2022 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 67k | $2.94 | $197k | | 01/25/2022 |
| 01/18/2022 | Aptose Biosciences Inc. | APTO | Grant | Director Stock Option (Right to Buy) | 50k | $1.34 | $67k | | 01/18/2022 |
| 10/08/2021 | PHOENIX BIOTECH ACQUISITION CORP. | | Other (acquisition) | Class B Common Stock | 17.5k | $0.00 | $0 | By Phoenix Biotech Sponsor, LLC | 10/08/2021 |
| 06/03/2021 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Non-employee Director Stock Option (right to buy) | 14k | $3.53 | $49.4k | | 06/03/2021 |
| 05/27/2021 | ZOGENIX, INC. | ZGNX | Grant | Stock Option (Right to Buy) | 22k | $17.83 | $392.3k | | 05/27/2021 |
| 01/26/2021 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 32k | $5.78 | $185k | | 01/26/2021 |
| 01/12/2021 | eFFECTOR Therapeutics, Inc. | | Other (disposition) | Class B Common Stock | 17.5k | $0.00 | $0 | By LWAC D&O LLC | 01/12/2021 |
| 01/04/2021 | Aptose Biosciences Inc. | APTO | Grant | Director Stock Option (Right to Buy) | 50k | $4.37 | $218.5k | | 01/04/2021 |
| 09/21/2020 | ZOGENIX, INC. | ZGNX | Grant | Stock Option (Right to Buy) | 20k | $22.82 | $456.4k | | 09/21/2020 |
| 06/03/2020 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Non-employee Director Stock Option (right to buy) | 16k | $0.00 | $0 | | 06/03/2020 |
| 05/15/2020 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (Right to Buy) | 49.2k | $4.05 | $199.4k | | 05/15/2020 |
| 03/11/2020 | Aptose Biosciences Inc. | APTO | Grant | Director Option Grant | 50k | $7.08 | $354k | | 03/11/2020 |
| 03/11/2020 | Aptose Biosciences Inc. | APTO | Grant | Director Option Grant | 50k | $0.00 | $0 | | 03/13/2020 |
| 01/31/2020 | Aptose Biosciences Inc. | APTO | Grant | Director Option Grant | 65k | $6.91 | $449.2k | | 01/31/2020 |
| 05/09/2019 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Non-employee Director Stock Option (right to buy) | 9.2k | $13.23 | $121.3k | | 05/09/2019 |
| 02/27/2019 | PhaseBio Pharmaceuticals Inc | PHAS | Grant | Non-employee Director Stock Option (right to buy) | 8.9k | $3.15 | $28k | | 02/27/2019 |
| 01/29/2019 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 27.7k | $8.43 | $233.6k | | 01/29/2019 |
| 01/02/2019 | Aptose Biosciences Inc. | APTO | Grant | Stock Options (Right to Buy) | 40k | $1.91 | $76.4k | | 01/02/2019 |
| 01/24/2018 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 16k | $11.69 | $187k | | 01/24/2018 |
| 09/22/2017 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 7.5k | $7.47 | $56k | | 09/22/2017 |
| 06/28/2017 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 15k | $5.50 | $82.5k | | 06/28/2017 |
| 01/19/2017 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 30k | $1.72 | $51.6k | | 01/19/2017 |